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Abstract Plaques containing the aggregated b-Amyloid (Ab) peptide in the brain
are the main indicators of Alzheimer’s disease. Fibrils, the building blocks of
plaques, can also be produced in vitro and consist of a regular arrangement of the
peptide. The initial steps of ﬁbril formation are not well understood and could
involve smaller aggregates (oligomers) of Ab. Such oligomers have even been
implicated as the toxic agents. Here, a method to study oligomers on the time scale
of aggregation is suggested. We have labeled the 40 residue Ab peptide variant
containing an N-terminal cysteine (cys-Ab) with the MTSL [1-oxyl-2,2,5,5-tetra-
methyl-D-pyrroline-3-methyl] methanethiosulfonate spin label (SL-Ab). Fibril
formation in solutions of pure SL-Ab and of SL-Ab mixed with Ab was shown by
Congo-red binding and electron microscopy. Continuous-wave 9 GHz electron
paramagnetic resonance reveals three fractions of different spin-label mobility: one
attributed to monomeric Ab, one to a multimer (8–15 monomers), and the last one
to larger aggregates or ﬁbrils. The approach, in principle, allows detection of
oligomers on the time scale of aggregation.
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Magnetic Resonance1 Introduction
The aggregation of the b-Amyloid (Ab) peptide into ﬁbrils and ultimately plaques is
the chief indicator of Alzheimer’s disease. Information on the structure of the ﬁbrils
had been obtained from microscopy techniques such as cryo-electron microscopy
(cryo-EM) [1], atomic force microscopy (AFM), scanning tunneling microscopy
(STM) [2], solid-state nuclear magnetic resonance (ss-NMR) [3–5] and liquid
solution NMR [6] methods. The ﬁbrils of Ab and other amylogenic proteins, such as
a-synuclein, have been studied by spin-label electron paramagneticresonance (EPR),
targeting the mobility of the spin-label and spin–spin interaction [7–9]. Even X-ray
crystallography was possible on nanocrystals grown from a short peptide model [10].
Theaggregationprocessitself,particularlytheroleofoligomersintheaggregation,is
still much less understood. Speciﬁc interest in such smaller aggregates stems from the
suggestion that small, oligomeric aggregates and protoﬁbrils, rather than fully formed
ﬁbrils could be responsible for the toxicity of the Ab-peptide. Studies targeting
oligomers of Ab via diffusion measurements by NMR [11], size-exclusion chromatog-
raphy[12],infraredspectroscopy[13]andmassspectrometry[14]havebeenpublished.
In the present study, we investigate the potential of EPR to detect early stages of
the aggregation of the Ab-peptide. Whereas previous EPR was performed on ﬁbrils
separated from the aggregating solution after a longer incubation time [7–9], the
present investigation focuses on the reaction mixture to study the process of
aggregation itself. We employ the spin-labeled cysteine mutant SL-Ab and the
unlabeled Ab (wild-type Ab1–40) to diamagnetically dilute the spins [7, 8]. Earlier,
EPR signatures of aggregation in a prion protein were described. These signatures
were assigned to aggregates large enough to be immobilized on the EPR time scale
[15]. Recently, an abstract about EPR on Ab(1–25) [16] has been published. We
demonstrate that signatures of oligomers can be detected by our methodology and
that different species coexist in the aggregating solution. The approach should make
it possible to follow the time scale of the aggregation.
2 Materials and Methods
The peptide Ab-(1–40) as well as its cysteine mutant Cys-(Ab) (H-Cys-Asp-Ala-   -
Val-OH) was purchased from AnaSpec (purity[95%), the solvent dimethyl
sulfoxide (DMSO) was purchased from Biosolve (purity 99.8%), spin probes MTSL
[1-oxyl-2,2,5,5-tetramethyl-D-pyrroline-3-methyl] methanethiosulfonate were pur-
chased from Toronto Research Chemicals Inc. (Brisbane Rd., NorthYork, ON,
Canada, M3J 2J8) and were used without further puriﬁcation. Phosphate-buffered
saline (PBS, 12 mM Na2HPO4, 137 mM NaCl, 2.7 mM KCl, 1.8 mM KH2PO4 at
pH 7.4) was used to initiate aggregation of Ab.
2.1 Spin Labeling
Cys-(Ab) was dissolved in DMSO (2.5 mg/ml), Tris–HCl buffer (10 mM, pH 8.8,
sonicated under vacuum) was added to a ﬁnal peptide concentration of 0.33 mg/ml.
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123After adding a ﬁvefold molar excess of MTSL spin label (MW = 264.3 g/mol), the
solution was incubated under shaking for 60 min.
Spin-labeled Cys-(Ab) (SL-Ab) was puriﬁed on a semi-preparative Gemini
 C18
column (Phenomenex
), 250 mm 9 10 mm, 5 lm particle size, by applying a
gradient of B in A, C kept isocratic at 10% and by increasing the amount of B from
10 to 70% [A, H2O; B, acetonitrile; C, H2O 1 vol% aqueous triﬂuoroacetic acid
(TFA)]. The puriﬁed SL-Ab was analyzed by liquid chromatography-mass
spectrometry. The analytical high performance liquid chromatography column
was Gemini
 C18 (Phenomenex
), 50 mm 9 4.6 mm, 3 lm particle size, applying
a gradient of B in A (10–90% B), C kept isocratic at 10% (A, H2O; B acetonitrile; C,
H2O 1 vol% aqueous TFA). The mass spectrometer was a PE Sciex API 165 single
quadrupole instrument. Found: m/z = 1540.13 for (M ? 3H)
3? (calculated for 100%
abundance, 1539.76) and m/z = 1155.27 for (M ? 4H)
4? (calculated for 100%
abundance, 1155.07). Retention time, tr = 5.69 min. The peptide was lyophilized
and stored in the freezer (-20C) until used.
2.2 Samples for EPR Spectroscopy, Room Temperature EPR
Samples of SL-Ab in DMSO were prepared as a reference with a peptide
concentration of 0.22 mM. The SL-Ab samples in PBS were prepared as
diamagnetically diluted samples (dd-SL-Ab), containing a molar fraction of 14 or
40% labeled peptide. The total peptide concentration was kept constant at 0.55 mM
for all room temperature EPR measurements containing 76 lM and 0.22 mM
SL-Ab for the 14 and 40% labeled samples, respectively. Samples have been diluted
in an aqueous PBS solution to trigger aggregation. The concentration of DMSO in
such samples has been kept below 10%. For room temperature measurements,
samples of 10–15 ll peptide solution were drawn into Blaubrand 50 ll capillaries.
Often, a white precipitate was observed. Each experiment shown was repeated at
least twice. In total, more than 30 samples were investigated and methods were
varied in a limited range to improve sample preparation and aggregation conditions.
The database is not sufﬁcient to systematically study sample-to-sample variations
yet. The measurements were made immediately after dissolving in PBS. The
samples have been incubated at room temperature in these capillaries as well as in
vials under shaking (800 rpm) for 9 days and measured again to monitor time-
dependent effects. Beyond this, no attempts were made to vary the aggregation
protocol as described in refs. [17–21].
2.3 Filtration Experiment
A 40% SL-Ab sample with a total concentration of 0.55 mM protein was dissolved
in PBS and was left to incubate for 40 min. Subsequently, it was ﬁltered using a
30 kDa membrane ﬁlter (Vivaspin 500, Vivascience, Satorius). Three hours after
starting the incubation, a sample of the initial solution, the retentate and the ﬁltrate
were measured. The ﬁltrate was measured as obtained, and 150 ll of PBS was
added to the retentate (ca. 25 ll) just before measuring.
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1232.4 Spin Concentration
The spin concentration in the samples in PBS was determined relative to that of the
DMSO stock solution of SL-Ab by double integration of the ﬁrst-derivative EPR
spectra. The errors of this method are around 15% due to difﬁculties with the base-
line subtraction in the spectra.
2.5 Frozen-Solution EPR
For measurements in frozen solution, a droplet of SL-Ab stock solution was diluted
in the EPR tube (4 mm o.d.) to a concentration of 80 lM in PBS or DMSO,
respectively. After incubation for 5 min, 20% (v/v) glycerol has been added.
Measurements were performed at 120 K after shock freezing the sample in liquid
nitrogen.
2.6 EPR Spectrometer
The X-band continuous-wave (cw) EPR measurements were performed on an
Elexsys E 680 spectrometer (Bruker, Rheinstetten, Germany) equipped with a
helium gas-ﬂow cryostat and a rectangular cavity. A modulation frequency of
100 kHz was used for all measurements; the accumulation time for the spectra
shown and for those used for simulation of the line shape was 40 min per spectrum.
Information on the time course of aggregation is contained in the ratio of the fast,
intermediate and slow components. It can be obtained from spectra taken in
5–10 min range, making use of the line shape determined for spectra with longer
accumulation time. Measurements in liquid solution at room temperature were done
at 6.31 mW microwave power and modulation amplitudes of 0.25 and 1.4 G. The
larger modulation amplitude was used to obtain a better signal-to-noise ratio of
broad lines. The sample height was carefully adjusted in order to be sensitive to that
part of the solution, where white precipitates have been observed. For measurements
in frozen solution at 120 K, a modulation amplitude of 2 G and microwave power of
0.05 mW have been used. Spin concentrations were compared via the double
integral of the spectra of Ab in DMSO and in PBS.
2.7 Simulations of EPR Spectra
The spectra were simulated using Matlab and the EasySpin [22] package. For room
temperature spectra, up to three spectral components featuring different degrees of
rotational mobility of the spin labels have been taken into account. For these
spectral contributions, the following parameters were used: g = [2.009006,
2.00687, 2.003] [23], and Axx = Ayy = 12 and 13 MHz in DMSO and PBS,
respectively. Simulating the spectrum of SL-Ab in DMSO and of the fast
component of the PBS samples, a hyperﬁne interaction with six carbon sites was
taken into account assuming a natural abundance of
13C of 1%. An isotropic
hyperﬁne splitting A13C = 17 MHz was used. Over-modulation effects were taken
into account if appropriate.
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123The simulations for both normal and over-modulated spectra are possible with
the EasySpin program and all parameters for narrow lines are the same when the
function for an over-modulated spectrum is used (all spectra shown are over-
modulated spectra).
For the low-temperature spectra, the same g tensor as for room temperature was
used with Axx = Ayy = 12 MHz for both DMSO and PBS.
2.8 Interpretation of Rotation Correlation Times
Rotation correlation times were interpreted with the Stokes–Einstein relation
sR ¼
4pga3
3kT
A spherical approximation is used for the shape of the aggregates. For the fast
rotating fraction of the sample, a sR of ca. 0.15 ns is obtained. Using a viscosity of
water of g = 1 9 10
-3 kg s/m at 20C, a volume of 606 A ˚ 3 results, which is close
to the volume of 529 A ˚ 3 obtained from the sR of Ab in DMSO (g = 1.99 kg s/m,
sR = 0.26 ns). For the fraction with the intermediate sR (sR = 2.3 ns), a volume of
9,304 A ˚ 3 results.
2.9 Congo-Red Binding Assay
Aggregation in EPR samples (dd-SL-Ab) has been checked additionally by the
Congo-red binding assay. The optical absorbance has been measured in the range
of 400–700 nm in cuvettes of 1 ml containing 9.84 lM Congo red in PBS before
and after adding peptide solution to a ﬁnal peptide concentration of 8.8 lM
[24, 25].
2.10 Electron Microscopy
Negative staining was performed by placing 5 ll of the peptide solution on glow-
discharged carbon supported by an EM grid. The droplet was allowed to absorb for
about 1 min and then blotted off. The samples were rinsed with a drop of water and
negatively stained with one drop of 3% uranyl acetate. The transmission electron
microscopy (TEM) was performed using a 100 kV Phillips CM10 transmission
electron microscope and images were recorded using a side-mounted charge-
coupled device (CCD) camera (Megaview III, SIS, Olympus).
3 Results
In order to verify that ﬁbrils are formed, the solutions of incubated Ab were
investigated using the Congo-red binding assay and electron microscopy.
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1233.1 Congo-Red Binding and Electron Microscopy
For the 14% labeled sample, the characteristic 4 nm shift of the absorbance at
487 nm, which is expected for ﬁbrils [24, 25], was observed. Electron microscopy
was performed on pure SL-Ab, on pure Ab and on mixed SL-Ab/Ab samples that
had been used for EPR. Figure 1 shows two representative EM pictures of 14%
SL-Ab, one at short times (after 5 min), and one after 15 min. After 5 min, the
majority of the features are very short ﬁbrils with a width of 5–10 nm and a length
of 20–100 nm, in agreement with the dimensions of protoﬁbrils found by EM [26]
and AFM [27]. After 15 min, very small ﬁbrils as above and larger ﬁbrils with a
width of 5–10 nm and a length of 100 nm–1 lm occur. Some of these larger
ﬁbrils are stuck together, but are still recognizable as ﬁbrils. Further, some
irregularly shaped clusters, presumably large aggregates of peptides, of diameter
200 nm–1 lm, are found. After 60 min, very small ﬁbrils as above, almost no
intermediate size ﬁbrils, and more condensed clustered aggregates with a diameter
of 200 nm–1 lm are found. After several days of aggregation, the main structural
features were clustered aggregates with a diameter of 200 nm–1 lm. Samples on
which EPR had been measured previously also showed ﬁbril signatures as
described above.
Fig. 1 TEM images of Ab.
After 5 min (top, scale bar
200 nm) and after 15 min of
incubation (bottom same scale
as top)
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123For EPR, samples of SL-Ab were measured in DMSO to obtain the free, soluble
state of Ab (Fig. 2a). The spectrum consists of three lines, which are due to the
hyperﬁne interaction (HFI) of the unpaired electron spin of the nitroxide group of
the MTSL with the N nucleus (I = 1). The small line width indicates a mobile spin
label. The simulation (Fig. 2a, dotted line) yields a rotation correlation time sr of
0.26 ns. In Fig. 2b, the spectrum of a sample containing 40% of SL-Ab mixed with
60% Ab in PBS buffer after 5 min of incubation is shown. The lines are broadened
relative to those of SL-Ab in DMSO, and additional lines are observed, suggesting a
superposition of different spectra. This is illustrated in Fig. 2c, where the three
components that are needed to simulate the spectrum are shown. These components
are subsequently referred to as fast, medium, and slow component and the spectral
simulation parameters are given in Table 1.
In Fig. 3, the spectrum of a sample containing 40% of SL-Ab mixed with 60%
Ab is shown for two selected time points. The spectra can be simulated well (see
Fig. 3b) with the parameters given in Table 1. Spin concentration determination
(see ‘‘Materials and Methods’’) revealed that the sample accounts for approx. 60%
of the total spins. A sample containing 14% of SL-Ab had essentially the same
spectra as those containing 40% SL-Ab, conﬁrming that the line shape of the spectra
of these samples is not affected by spin–spin interaction (see below). To test the
332 334 336 338 340 342
c
b
B, mT
a
Fig. 2 Room temperature EPR
spectra of SL-Ab. a SL-Ab in
DMSO: solid line experiment,
dotted line simulation. b 40%
SL-Ab in PBS after 5 min of
incubation: solid line
experiment, dotted line
simulation. c Spectrum of 40%
SL-Ab in PBS after 10 min
incubation and simulation of the
spectrum with three
components: dotted light gray
line fast, dark gray line medium,
solid gray line slow component
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123inﬂuence of the aggregation conditions, spectra of samples kept still in the
measurement capillaries for 9 days were compared to those of a fresh sample drawn
from the original incubation solution that was shaken for the same amount of time.
In all cases, the spectra were identical, revealing that there is no inﬂuence of the
sample container (measurement tube or glass vial—see ‘‘Materials and Methods’’)
or agitation of the sample (aggregation under resting conditions or during shaking).
Table 1 EPR parameters of 40% SL-Ab in PBS at room temperature for different incubation times (see
text). sR is the rotation correlation time, Azz is the hyperﬁne splitting along the z-direction, lw is the
component line width of the simulation and % stands for percentage of the given component to the total
spectrum
Fast Medium Slow
sR
(ns)
Azz
(MHz)
lw
(MHz)
% sR
(ns)
Azz
(MHz)
lw
(MHz)
% Azz
(MHz)
lw
(MHz)
%
10 min 0.1 109.5 0.125 5.5 2.9 109.5 0.125 58 96 0.49 36.5
5–6 h 0.17 109.3 0.125 14 2.3 109.3 0.125 52 96 0.49 34
25 days 0.12 109.3 0.125 9.5 2.3 109.3 0.125 53.5 95 0.49 37.5
Error ±0.03 ±0.2 ±0.005 ±1 ±0.3 ±0.2 ±0.005 ±1 ±0.5 ±0.01 ±1
332 334 336 338 340 342
b
B, mT
a
Fig. 3 Room-temperature EPR
spectra of 40% SL-Ab in PBS
after 5 h (solid line) and after
25 days (dotted line)( a).
Spectrum of 5 h incubation
(solid line) and simulation
(dotted line)( b)
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1233.2 Filtration Experiment
A possible interconversion of species found in the mixture can be checked by
ﬁltration of the solution with a membrane ﬁlter with the suitable molecular weight
(MW) cutoff. Here, a sample of 40% SL-Ab was ﬁltered through a 30 kDa MW-
cutoff ﬁlter (see ‘‘Materials and Methods’’). Spectra of the ﬁltrate, the retentate and
the unﬁltered solution of the sample that was subjected to the ﬁltration procedure
were measured (see ‘‘Materials and Methods’’). A simulation using the parameters
in Table 2 gave good agreement with the data. The retentate contains a signiﬁcant
contribution of the fast component, and the ﬁltrate has a composition that is similar
to that of the sample that was not ﬁltrated. As larger aggregates cannot pass the ﬁlter
(nominally, a cutoff of 30 kDa corresponds to a heptamer of Ab), the amount of
intermediate and slow fractions should be greatly reduced in the ﬁltrate, and no fast
component is expected in the retentate. This suggests that the species responsible for
these fractions can interconvert on the time scale of the ﬁltration experiment, in this
case of several hours.
3.3 Frozen-Solution EPR
Frozen-solution EPR was performed on samples containing pure SL-Ab in DMSO
and in PBS buffer with an incubation time of 5 min before freezing. The
superposition of the two spectra (Fig. 4a) shows that Azz of SL-Ab in DMSO is
smaller than in PBS and that the spectrum in PBS has some line broadening.
Different Azz values indicate polarity differences in the environment of the spin
label [28]. The smaller Azz of SL-Ab in DMSO reﬂects the lower polarity of DMSO
relative to the aqueous buffer. The spectrum in DMSO is well simulated with a
single species, whereas the spectrum in PBS needs to be simulated as a
superposition of two species, one with a component line width identical to that in
DMSO, the second with a broader component line width (see Table 3). Under the
conditions of the experiment, the broadening can only be due to spin–spin
interaction. The distance between the spins is estimated from the comparison of the
Table 2 Results of ﬁltration experiment. The EPR parameters of the spectra of the ﬁltrate and the
retentate of the ﬁltered solution and of the unﬁltered solution of the 40% SL-Ab in PBS are given (see
text). sR is the rotation correlation time, Azz is the hyperﬁne splitting along the z-direction, lw is the
component line width of the simulation and % stands for percentage of the given component to the total
spectrum
Fast Medium Slow
sR
(ns)
Azz
(MHz)
lw
(MHz)
% sR
(ns)
Azz
(MHz)
lw
(MHz)
% Azz
(MHz)
lw
(MHz)
%
Solution 0.21 109.75 0.13 18 2.3 109.75 0.13 51 96 0.49 31
Retentate 0.31 109.75 0.13 13 2.7 109.75 0.13 53 96 0.49 34
Filtrate 0.17 109.75 0.13 24 2.3 109.75 0.13 45.5 95 0.49 30.5
Error ±0.03 ±0.2 ±0.005 ±1 ±0.3 ±0.2 ±0.005 ±1 ±0.5 ±0.01 ±1
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123second moment [29] of the broadened component with the narrower component of
the spectra. For a pair of interacting spins this results in a distance of 1.2 nm.
3.4 Interpretation of the Rotation Correlation Times of the Fractions
Molecular volumes corresponding to the fast and intermediate fractions are
calculated from the sr values in ‘‘Materials and Methods’’. For the fast fraction, a
volume of 606 A ˚ 3 results, which is close to the volume of 529 A ˚ 3 obtained from the
sR of SL-Ab in DMSO. This is about half of the calculated volume of Ab that is
obtained from the molecular weight of Ab and assuming a density of 1.52 g/cm
3 as
330 332 334 336 338 340 342 344
b
B, mT
a
2A
zz
Fig. 4 Frozen-solution EPR
spectrum of SL-Ab in DMSO
and PBS (a). Simulation
(dotted line) of the spectrum
in PBS (solid line)( b)
Table 3 Parameters of the frozen-solution EPR spectrum of 100% SL-Ab in DMSO and PBS. Azz is the
hyperﬁne splitting along the z-direction, lw is the component line width of the simulation
Narrow Broad
Azz (MHz) lw (MHz) Azz (MHz) lw (MHz)
DMSO 98 ± 0.5 0.75 ± 0.02 n.a. n.a.
PBS 101 ± 1 0.75 ± 0.02 101 ± 8 1.9 ± 0.3
a
a The percentage of the broadened component is 36 ± 3%
n.a. not applicable
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123suggested in Fischer et al. [30]. The smaller volume determined experimentally is
most likely due to the mobility of the spin label, which shortens sR. On the other
hand, the viscosity of the solution of Ab in PBS is certainly larger than that of pure
water used in the calculation; thus in this respect the calculated molecular volume is
an upper limit.
The volume of 9,304 A ˚ 3 for the fraction with the intermediate sR indicates a
multimer of Ab. To estimate the number of Ab peptides in such an aggregate, the
molecular volume can be taken (i) from the monomer volume deduced from the fast
fraction, or (ii) from the volume of Ab expected from the molecular weight. In the
ﬁrst case, a 15-mer results. This number derives from the ratio of sR values measured
in the same sample, so the absolute viscosity does not play a role. It assumes,
however, that the local mobility of the spin label in the aggregate is the same as in the
monomer. Most likely, the mobility of the spin label in the aggregate is lower than in
the monomer, suggesting that the true number of molecules in the aggregate is
smaller than 15. In the second case, the number of molecules in the aggregate is
eight. In that case, the higher viscosity of the Ab-PBS solution relative to water is not
taken into account, which, for the same reasons as discussed above for the monomer,
would lead to an underestimate of the number of molecules in the aggregate. We,
therefore, place the lower and upper limits of the number of molecules in aggregates
of the intermediate fraction at 8 and 15 molecules, respectively.
4 Discussion
We have spin-labeled the Cys-Ab variant with the MTSL label (SL-Ab) and have
shown by the Congo-red assay and electron microscopy that SL-Ab and its mixtures
with Ab form the same type of ﬁbrils as the pure Ab under conditions as close as
possible to those of the EPR experiments. Fibrils are observed for all these samples,
even at the earliest time points tested, and ﬁbril growth is observed for the ensuing
hours. The ﬁbrilization occurs within minutes and over a time scale of hours the
ﬁbrils grow.
A large body of literature concerns differences in aggregation kinetics and ﬁbril
morphology that can be induced by changing aggregation conditions (see, for
example, refs. [17–21]). In the present exploratory study, we chose one set of
conditions that are reproducible and yield ﬁbrils under the conditions of the EPR
experiment.
In EPR, the difference between the spectra in DMSO and PBS gives clear
evidence of aggregation. In the frozen solution spectra, line broadening can only be
due to the spin–spin interaction. Consequently, in the fraction of the sample with the
broadened component, the distance between spin labels is closer than what would be
expected for monomers randomly distributed in solution, suggesting aggregation.
For this fraction, a distance of 1.2 nm results for a spin pair.
For the N-terminal region of the Ab, distances in a lateral direction, i.e.,
perpendicular to the ﬁbril axis are around 4 nm [4, 31], whereas within the b-sheet
core of the ﬁbrils, intra-strand distances, i.e., distances in the direction along the
ﬁbril axis of 0.4 nm are expected (Protein Data Bank entry, 2beg.pdb [31]). Due to
Monitoring Ab Aggregation by EPR 219
123the 1/r
3 dependence of the dipolar interaction, lateral distances are so large that they
should not contribute signiﬁcantly to the broadening. The intra-strand distance, on
the other hand, should result in a larger broadening than experimentally observed.
Furthermore, in this direction, interactions with multiple partners are expected,
causing even larger broadening than that of a pair interaction. In our construct,
however, the spin label is in the N-terminal region of Ab, i.e., outside the b-sheet
region of the ﬁbrils. Spin-label EPR on fully developed ﬁbrils has shown that spin
labels in the N-terminal region of Ab [8] and of other ﬁbril forming proteins [9] are
less affected by ﬁbrilization than spin labels in the central regions of the b sheet.
We, therefore, attribute the smaller broadening to an overall larger distance between
spin labels because of a distribution of conformations within the N-terminal region
of Ab that also diminishes second-neighbor interactions.
The broadening of the room-temperature spectra reveals a reduced mobility of
the spin labels. Aggregation can reduce the mobility of the spin label, if the spin
label becomes trapped within the aggregates, and if the aggregates are sufﬁciently
large to be rotating slowly on the EPR time scale.
The room temperature EPR spectra of the peptides in PBS revealed three
components, corresponding to fractions of the samples in which the spin labels have
different mobility. The rotation-correlation time sR of the fastest component is
attributed to the monomeric Ab. The medium component corresponds to an
oligomer with a minimum number of 8 and a maximum number of 15 molecules
and the slow one to larger aggregates that are immobilized on the EPR time scale
(see ‘‘Results’’).
The ﬁltration experiment shows that monomers must be formed from the larger
aggregates that do not pass the membrane ﬁlter (monomer-like SL-Ab in the
retentate) and that larger aggregates are formed from the smaller aggregates passing
the 30 kDa ﬁlter, suggesting interconversion between species on the time scale of
hours.
With respect to the time course of aggregation, we ﬁnd evidence of aggregation
at the earliest times. The frozen solution experiment reﬂects a time point of 5 min
(see ‘‘Filtration Experiment’’), and, in the room temperature experiment, the
broadened components are evident from the earliest time points (see Figs. 2, 3;
Table 1). The composition of the spectra corresponding to different time points
reveals percentage changes of the components that are signiﬁcant given the error of
the simulation parameters. For the present set of experiments, however, the
differences are close to the sample-to-sample variation, so at present we disregard
the temporal changes of these components.
This investigation shows that spectral signatures of aggregation can be obtained
by cw EPR and that, in principle at least, information on aggregate size and the time
development thereof could become accessible. We show that the method should be
sensitive enough to unravel oligomers of a wide variety of sizes and thus would be
able to detect the time development of oligomers in aggregating samples. Even
small oligomers of a couple of Ab molecules should be detectable and time
resolution down to several minutes can be achieved. In this respect it surpasses the
presently most widely used chromatographic techniques. Positioning the spin label
closer to the b-sheet core of Ab will reduce the local mobility of the spin label once
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123Ab forms part of an oligomer or aggregate, improving the sensitivity of the spin-
label motion to the properties of the aggregate. The most faithful reporters of the
aggregate motion would be spin labels that form part of the peptide backbone, such
as the TOAC label [32, 33] or other non-natural amino-acid replacement labels [34].
The challenge, however, is to incorporate these spin labels into the Ab sequence and
to purify the resulting product. Future studies based on the Ab constructs mentioned
will have a higher sensitivity to the formation of aggregates in the sample. Thereby,
a reﬁned picture of the initial stages of aggregation will be obtained, a step towards
understanding the ﬁbrillization process.
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